Catalog Products » HLA-A*24:02&B2M&MAGE-A3 (IMPKAGLLI) Monomer, His & Avi, Human
Manual
Manual
COAs

HLA-A*24:02&B2M&MAGE-A3 (IMPKAGLLI) Monomer, His & Avi, Human

Melanoma antigen gene A3 (MAGE-A3) is one of the most immunogenic cancer testis antigens and is common in various types of cancers. MAGE-A3 can be considered as a predictor for poor prognosis and an option for vaccine immunotherapy in patients with PCa.
$340.00
Z06635-100

Ask us a question
Product Introduction
Species Human
Protein Construction
HLA-A*24:02&B2M&MAGE-A3 (IMPKAGLLI) Monomer [Gly25-Thr305(HLA-A*24:02), Ile21-Met119(B2M) and IMPKAGLLI peptide]
Accession # AAA59600.1(HLA-A*24:02)&P61769(B2M)&IMPKAGLLI		 His Avi
N-term C-term
Purity > 95% as determined by Bis­Tris PAGE 
Endotoxin Level Less than 1EU per μg by the LAL method.
Expression System HEK293
Theoretical Molecular Weight 50.20 kDa
Apparent Molecular Weight Due to glycosylation, the protein migrates to 55-60 kDa based on Bis-Tris PAGE result.
Formulation Lyophilized from 0.22μm filtered solution in PBS (pH 7.4).
Reconstitution Centrifuge the tube before opening. Reconstituting to a concentration more than 100 μg/ml is recommended. Dissolve the lyophilized protein in distilled water.
Storage & Stability Upon receiving, the product remains stable for 6 months at -20℃ or below. Upon reconstitution, the product should be stable for 3 months at -80℃. Avoid repeated freeze-thaw cycles.
Back

HLA-A*24:02&B2M&MAGE-A3 (IMPKAGLLI) Monomer, His & Avi, Human

The purity of HLA-A*24:02&B2M&MAGE-A3 (IMPKAGLLI) Monomer, His & Avi, Human is greater than 95% as determined by SEC-HPLC. »

HLA-A*24:02&B2M&MAGE-A3 (IMPKAGLLI) Monomer, His & Avi, Human

HLA-A*24:02&B2M&MAGE-A3 (IMPKAGLLI) Monomer, His & Avi, Human on Bis-Tris PAGE under reduced condition. The purity is greater than 95%. »

<
>

Background
Target Background Melanoma antigen gene A3 (MAGE-A3) is one of the most immunogenic cancer testis antigens and is common in various types of cancers. MAGE-A3 can be considered as a predictor for poor prognosis and an option for vaccine immunotherapy in patients with PCa.
Synonyms Melanoma-associated antigen 3; MZ2-D; MZ2D; MZ2-D; CT1.3; MAGE-3
Back

For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use.